Roche, Katherine
- National Institute of Neurological Disorders and Stroke (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,197
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.8M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,197
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Roche, Katherine as a PI. Multi-PI records show the full award amount for context.
- 1ZIANS003140-10ZIAContact PIRegulation of Neuroligins and Effects on Synapse Number and Function$2Maward amount
- 1ZIANS002994-22ZIAContact PISubunit-Specific Regulation Of Glutamate Receptors$1.8Maward amount
Award organization
Organizations that administered FY2023 awards listing Roche, Katherine as a PI.
FY2023 award administered by National Institute of Neurological Disorders and Stroke ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute of Neurological Disorders and Stroke
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #7574
- 2009$2M Cumulative Funding
- 2009Entered Top 25% NationallyRanked #2263
- 2010$5M Cumulative Funding
- 2012$10M Cumulative Funding
- 2013Entered Top 10% NationallyRanked #1702
- 2018$25M Cumulative Funding
- 2021Entered Top 5% NationallyRanked #780